Metabolism of olaquindox in rat and identification of metabolites in urine and feces using ultra‐performance liquid chromatography/quadrupole time‐of‐flight mass spectrometry
Authors:
- 14 March 2011
- journal article
- research article
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 25 (7) , 889-898
Abstract
Olaquindox (OLA), N ‐(2‐hydroxyethyl)‐3‐methyl‐2‐quinoxalincarboxamide‐1,4‐dioxide, is an antimicrobial and growth‐promoting agent for animals, which has been banned or allowed only limited use for its potential toxicity. To thoroughly understand the metabolic pathways, metabolism of OLA in rat was studied using ultra‐performance liquid chromatography coupled to quadrupole time‐of‐flight mass spectrometry with MS E and mass defect filtering techniques. Twenty metabolites (M1–M20) were detected in rat feces and urine, of which nine phase I metabolites (M6, M7, M11–M16) and four phase II metabolites (M17–M20) were found in vivo for the first time. The structures of metabolites were reliably characterized on the basis of accurate mass and fragment ions in MS E spectra. The major metabolic pathways reported previously in pigs, including reduction of N→O groups, oxidation of the alcohol and hydrolysis, were also confirmed in this study. In addition, hydroxylation of the methyl group, N‐dehydroxyethylation and glucuronidation were also proved to be the important metabolic pathways, which contribute to improving our knowledge about in vivo metabolism of OLA. Copyright © 2011 John Wiley & Sons, Ltd.Keywords
This publication has 15 references indexed in Scilit:
- Investigation of Bioactivation of Ticlopidine Using Linear Ion Trap/Orbitrap Mass Spectrometry and an Improved Mass Defect Filtering TechniqueChemical Research in Toxicology, 2010
- Mass defect filter technique and its applications to drug metabolite identification by high‐resolution mass spectrometryJournal of Mass Spectrometry, 2009
- Generic dealkylation: a tool for increasing the hit‐rate of metabolite rationalization, and automatic customization of mass defect filtersRapid Communications in Mass Spectrometry, 2009
- Liquid chromatography–mass spectrometry in in vitro drug metabolite screeningDrug Discovery Today, 2009
- Mass defect profiles of biological matrices and the general applicability of mass defect filtering for metabolite detectionRapid Communications in Mass Spectrometry, 2008
- Metabolism of olaquindox in rat liver microsomes: structural elucidation of metabolites by high‐performance liquid chromatography combined with ion trap/time‐of‐flight mass spectrometryRapid Communications in Mass Spectrometry, 2008
- MS E with mass defect filtering for in vitro and in vivo metabolite identificationRapid Communications in Mass Spectrometry, 2007
- Current and future trends in the application of HPLC-MS to metabolite-identification studiesDrug Discovery Today, 2007
- Molecular mechanism of mutagenesis induced by olaquindox using a shuttle vector pSP189/mammalian cell systemMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2006
- UPLC/MS E ; a new approach for generating molecular fragment information for biomarker structure elucidationRapid Communications in Mass Spectrometry, 2006